The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...
As fall approaches, so does respiratory syncytial virus or RSV season. This year, there are more options for those most ...
With cold and flu season around the corner, Doctors recommend receiving the RSV vaccine ahead of the holidays.
Researchers found that vaccine effectiveness was 80% and 81% against RSV-associated hospitalizations and against RSV-associated critical illness among 28,271 hospitalizations for RSV-like ...
This season will be the first time in Ontario that nirsevimab (sold under the brand name Beyfortus) is used to protect babies ...
The Royal Australian College of GPs (RACGP) has lauded the Federal Government's announcement of $174.5 million to provide free RSV vaccination during ...
Beyfortus ® offers timely protection against RSV lower respiratory tract disease ... life-changing treatment options and life-saving vaccine protection to millions of people globally, while ...
Starting Nov. 4, doses of RSV immunization will also be available for infants and high-risk children up to 24 months ...
Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...